VA HB1348 | 2025 | Regular Session
Note: Carry Over of previous HB1348
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 12 2024 - 25% progression
Action: 2024-11-18 - Left in Appropriations
Pending: House Appropriations Committee
Text: Latest bill text (Comm Sub) [HTML]
Status: Introduced on January 12 2024 - 25% progression
Action: 2024-11-18 - Left in Appropriations
Pending: House Appropriations Committee
Text: Latest bill text (Comm Sub) [HTML]
Summary
Department of General Services; Office of Pharmaceutical Services; report. Establishes in the Department of General Services an Office of Pharmaceutical Services to develop and execute a plan to consolidate state agency prescription drug purchasing and pharmacy benefit management programs to increase efficiency in prescription drug purchasing and constrain spending on prescription drugs. The bill directs the Department to provide to the Governor and the General Assembly an interim report on the development of the plan by November 1, 2024, and a final report on the plan by November 1, 2025.
Title
Pharmaceutical Services, Office of; establishes in Department of General Services, report.
Sponsors
Roll Calls
2024-02-06 - House - House: Reported from General Laws with substitute (20-Y 0-N) (Y: 20 N: 0 NV: 0 Abs: 2) [PASS]
2024-02-06 - House - House: Subcommittee recommends reporting with substitute (7-Y 0-N) (Y: 7 N: 0 NV: 0 Abs: 1) [PASS]
2024-02-06 - House - House: Subcommittee recommends reporting with substitute (7-Y 0-N) (Y: 7 N: 0 NV: 0 Abs: 1) [PASS]
History
Date | Chamber | Action |
---|---|---|
2024-11-18 | House | Left in Appropriations |
2024-02-09 | House | Continued to 2025 in Appropriations (Voice Vote) |
2024-02-09 | House | Subcommittee recommends continuing to 2025 (Voice Vote) |
2024-02-09 | House | Impact statement from DPB (HB1348H1) |
2024-02-07 | House | Assigned App. sub: General Government and Capital Outlay |
2024-02-06 | House | Referred to Committee on Appropriations |
2024-02-06 | House | Committee substitute printed 24107241D-H1 |
2024-02-06 | House | Reported from General Laws with substitute (20-Y 0-N) |
2024-02-06 | House | Subcommittee recommends referring to Committee on Appropriations |
2024-02-06 | House | Subcommittee recommends reporting with substitute (7-Y 0-N) |
2024-02-06 | House | House subcommittee amendments and substitutes offered |
2024-02-01 | House | Impact statement from DPB (HB1348) |
2024-01-31 | House | Assigned GL sub: Procurement/Open Government |
2024-01-30 | House | Referred to Committee on General Laws (Voice Vote) |
2024-01-30 | House | Referred from Health and Human Services (Voice Vote) |
2024-01-12 | House | Referred to Committee on Health and Human Services |
2024-01-12 | House | Presented and ordered printed 24105140D |
Same As/Similar To
HB1348 (Carry Over) 2024-02-09 - Continued to 2025 in Appropriations by voice vote